SOLARA ACTIVE PHARMA SCIENCES LIMITED — Regulatory Filings 2021

Sep 20, 2021

Communication Address: Solara Active Pharma Sciences Limited Batra Centre No. 28. Sardar Patel Road. Post Box 2630 Guindy. Chennai - 600 032. India Tel : +91 44 43446700. 22207500 Fax : +91 44 22350278 E-mail : investors@solara.com www.solara.co.in

September 20, 2021

The BSE Limited The National Stock Exchange of India Limited Dalal Street, Mumbai – 400 001 Bandra (E), Mumbai – 400 051

Phiroze Jeejeebhoy Towers Exchange Plaza, Bandra-Kurla Complex

Scrip Code: 541540 Scrip Code: SOLARA

Dear Sirs,

Sub: Newspaper advertisement – Postal Ballot Notice

Please find enclosed copies of the newspaper advertisement titled 'Notice of Postal Ballot'. The advertisements appeared in Business Standard and Lokmat (Marathi version).

Kindly take on record of the above.

Thanking you,

Yours faithfully, For Solara Active Pharma Sciences Limited

S. Murali Krishna Company Secretary

Delhi, ¹⁷ September Initialpublicoffering(IPO)-boundOyohas

expanded its paid-up share capital base through ^a two-step process. The first step involves ^a 1:10 split of all equity and preference shares. As ^a next step, the equity shareholders have been allotted 3,999 bonus shares for eachshare theyholdand for preference shareholders, the conversion ratio to equity shares has been changed from 1:1 to 1:4,000, reveal recent regulatory filings. The expansion in share capital seems to

be in the run-up to the company's upcoming IPO to ensure themarket value per share reaches anaffordable andeasily tradeable price band. The SoftBankbacked traveltechnology firmis expected tofileitsdraft redherringprospectuswith the markets regulator Securities and Exchange Board of India in the next few months. Typically, prior to formally gettinglistedononeormorestockexchanges,companies with ^a small capital base issue bonus shares to existing shareholders to bring down the per-share price. This

share capitalviastocksplit,bonusNEHA ALAWADHI NewInan extraordinary general meeting held

ensures small retailinvestors and

share capital if ^a public offer is made to them. Such expansion of bonus shares has been carried out by Zomato, MobiKwik, and PolicyBazaar. Duringits pre-IPO stage, Zomato

passedaspecial resolutiontoissue~247.6 crore equity shares as bonus shares to existing shareholders in the 6,699:1 ratio and allotted 44,306,073,250 equity shares to all of its preference shareholders upon conversionofthe compulsory convertible preference shares. MobiKwik issued and allotted 15,617,940

equity shares to its ⁶⁷ equity shareholders,including its co-founders.

onSeptember 10,theshareholdersofOyo's parent Oravel Stays passed ^a shareholder resolution to consider and approve the sub-division of face value of equity and preference shares ofthe company. Following the share subdivision, according

to ^a filing dated September 11, 1,283,039,160 bonus shares were allotted to equity shareholders of the company in theratioof 1:3,999(3,999newequityshares for every1 equityshareofthe firmheldon September 10).Theeffectofthestocksplit and bonus issuance will also be provided to the employee stock option pool (ESOP) of the company, according to Oyo Global ESOP Plan 2018. The board also approved an appropriate

adjustment to the conversion ratio of preference shareholders on approval by shareholders for issuance of bonus equity shares as of September ¹⁰ in the ratio of 1:4,000 (in the proportion of 4,000 new equity shares for every ¹ preference share of the company held on September 10). Through this method, the company will allot equity shares to all its preference shareholdersuponconversionofthepreferenceshares held by them.

	www.bankofbaroda.in				बैंक ऑफ़ बड़ौदा Bank of Baroda
		TENDER NOTICE
	Mumbai.	Bank of Baroda, Facilities Management Department, Mumbai invites online Tender from prospective bidders for Proposed Interior Furnishing and allied works for offices at 14 th floor, Wing – B, Kohinoor Square IT Park, Dadar-West, Details are available under Tender Section of Bank's website www.bankofbaroda.in
Any Addendum/Corrigendum including modification in the Tender shall be notified only on Bank's official website. Bidders should refer the same before submission of their Bids. Last date of submission of online bids: 12.10.2021 up to 1500 hrs.
	Place: Mumbai			GENERAL MANAGER & HEAD
		Date: 18.09.2021		(FM, COA, RD & PD)	65/21-22
Sr.	Folio No.	Name / Joint Names		Shares Certificate Nos.	Distinctive Nos.
No.				From - To	From - To
			50 350	54400050-050 54400060-066	1287850127-176 1287850627-976
			100	54400070-071	1287851127-226
			50	54400073-073	1287851277-326
			100	54400081-082	1287851677-776
			250 100	54400092-096 54400109-110	1287852227-476 1287853077-176

till Sept22toconvert ESOPs into shares PRASOONSRIVASTAVANewDelhi,17

September Digital

payments and financial services firm Paytm has given time till September ²² to its employees todecide on converting their stock options ahead ofthe company's ~16,600 crore-IPO planned to be launched in October,accordingtosourcesawareofthe development.

Paytm's parent firm One97Communications has

sent out an email to its staff asking them whether they are interested in converting theirESOPs (EmployeeStock Option Plan) into shares,the sources said. According to theemail,thelastdayfor staff to exercise their ESOPs is September 22. For 'Designated Persons' to sell or buy shares, the deadline is September 27, while for KMPs (Key Management Personnel)andsellingshareholders,the date is September 22. "After the declarations of thesame, there will be no

further change in holding. Paytm has ^a total paid-up capital of ~60.72 crore, as of September," the source said. According to Registrar of Companies

(ROC) filing, as many as ²⁰⁰ Paytm employees have converted their ESOPs intoshares. "Basedon the paid-up capital and an expectedvaluationofaround~1.47 trillion, it will lead to immensewealthcreationforemployees," the source said. Paytm has reported the highest

gross merchandise value of ~4.03 trillion in the payments industry. Paytm is also facilitating loans

of up to ~100 crore through its lending partners andwillalsobear theinterest oftheseloans for sixmonths, so that employees are able to handle their finances better andyetbecomeproudshareholders ofthe company. According to the draft papers

Paytmstaffgettimeour capacities towards manufacturing Covid-19 vaccines. In2020, we had to take ^a very

(DRHP), it has disbursed 1.4 million loans in January-March, ⁵³ times higher than the number of loans (26,000)disbursedduring the same period of the previous year. Its wealth offering — digital gold and PaytmMoney'sMFandbroking services — has built ^a holding for itselfwitha combinedAUM of ~5,200 crore.

SOHINI DAS B

September iocon

Biologics (BBL) and Serum Institute Life Sciences (SILS) have entered an alliance to jointly develop and commercialise vaccines, biological drugs, andantibodytherapies. BBL will sell ^{a 15} per cent stake

to SILS at ^a post-money valuation of \$4.9 billion for access to ¹⁰⁰ million annual doses of vaccines, including Covid-19 shots,for ¹⁵ years. In addition to vaccines,the alliance

will develop antibodies targeting several infectious diseases like dengue, HIV, etc. The two companies will enter Service Level Agreements (SLAs) for manufacturing and distribution of the vaccines and antibodies. Work on the messenger RNA (mRNA) platform to develop future therapies and vaccines are also on the anvil. SILS is the subsidiary of Pune-basedSerumInstituteof

India (SII), the world's largest vaccine maker, which is making the AstraZeneca-Oxford Covid-19 vaccine, Novavax's Covid-19 jab among others. BBL is ^a Biocon subsidiary. Kiran Mazumdar-Shaw, executive

chairperson of Biocon&BioconBiologics,andAdar Poonawalla, CEO of SII, said the scope of the alliance waswaybeyondthe initial ¹⁰⁰ million annual doses. "Wehave diverted much of

and difficult call to temporarily put off our plans forourmonoclonal antibodies play. Through this tie-up, we canmaintainour ambitions in the biologics space as well," Poonawalla said. Shaw

agreed. She felt that this partnership that gives them access to SII's vaccine portfolio, including Covid-19 vaccines, for global markets, will be an additional growth driver for BBL. "Further, Biocon's research and manufacturinginfrastructure will be leveraged by the part-

nershipfor

variousopportuni-

ties

in the infectious disease

space,"

she said. Biocon

has an approved

biosimilars

portfolio in the US

andEurope,

andnowthey can

expand

their focus from non-

communicable

diseases to

infectious

diseases. Biocon

expects

to establish an R&D

division

for vaccines and bio-

logics

for communicable dis-

eases

to support the alliance.

An

important area of col-

laborationfor

the twopartners

the mRNA platform. As Poonawalla put it, "We are building ^a facility to handle ^a few hundred million doses, if not ^a billion doses of mRNA technologyproducts.Thiswilltake about two years to build and this allows BBL to do research and get the product ready,whichwecaneventuallymanufacture."He said at the moment the mRNA

technologiesmayhave some limitationsonlong-term efficacy. Once that is established, the cold chain requirements need to be improved. "For example, we are discussing that if we do embark on an mRNA candidate it should be stable at plus two to eight degrees and not minus ⁷⁰ degrees Celsius," he said. Leveraging their combined strength,thetwopartnerswish

to have better control over their raw material supplies. Poonawalla said vaccine and biologics production fluctuates attimeswithvariations in the global supply chain. "We plan to invest in this space to boostourpositionandbecomeself-reliant. Most probably, we would want to do (source) this in India itself," he said. The two companies would discuss

and explore common itemsofinterestandrawmaterials. Once they have shortlisted four or five major areas like resins, cell media, bioreactor bags etc, they can either gofor ^a focusedstrategy onprocurement.This couldbe either through an acquisition, or both can place long-term contractswith suppliers.

AlliancewillworkonmRNAplatformtodeveloptherapiesandvaccines SII join handsto diseases

toSerumInstituteLifeSciencesatapost-moneyvaluationof

Executive Chairperson Kiran Mazumdar-Shaw ⁿThetwocompanieswillenter

ⁿ BioconBiologicswill sell15% \$4.9billionⁿItwillhaveaccess to100 millionannualdosesofvaccines,includingCovid-19shots,of Serum vaccinesandantibodiesⁿThetwoplantobuildafacility tohandleafewhundredmilliondosesofmRNAtechproducts

servicelevelagreements

to

manufactureanddistribute

intwoyears

UNITED SPIRITS LIMITED Regd. Office: 'UB Tower',#24, Vittal Mallya Road, Bengaluru-560 001. Tel: +91 80 3985 6500; Fax: +91 80 3985 6862 Email: investor.india@diageo.com Website: www.diageoindia.com Corporate Identity Number: L01551KA1999PLC024991

Notice is hereby given that the Company has received requests from the following shareholders for issue of Duplicate Share Certificate(s) in lieu of the Original Share Certificate(s) reported to have been lost / misplaced. The share certificate(s) mentioned hereunder are therefore deemed to be cancelled and no transactions thereon would be recognized by the Company.

NOTICE OF LOSS OF SHARE CERTIFICATES

The public are hereby advised against dealing in any way with the above share certificates. Any person(s) who has / have any claims(s) in respect of the said share certificates should lodge such claim(s) along with all documentary evidences with the Company at its Registered Office within 15 days of the publication of this notice, after which no claim(s) will be entertained, and the Company will proceed to issue duplicate share certificates.

Sl.			No. of	Certificate	Distinctive Nos
Folio No. No		Name of the Shareholder	Shares	Number	From	To
01	MS190517	INDRANIL SENGUPTA SATYENDRA NATH SENGUPTA (Deceased)	500	8040	724492371	724492870
02	MS134526	CJGEORGE	500	14021	722781136	722781635

For UNITED SPIRITS LIMITED

Sd/- Mital Sanghvi

	or uuplicate cel tilicate(s).								50	54981702-702	1335857316-365
Sr.	Folio No.	Name / Joint Names		Shares Certificate Nos.	Distinctive Nos.				0	55921797-797	57915439-448
No.				From - To	From - To				40	55921797-797	58394999-038
	63097527	Ajay Zunzunwalla	$\overline{10}$	11423030-030	205833322-331				400	55938119-126	302906178-577
			0	50712086-086	1161912697-706				50	56365802-802	153528454-503
			20	62081489-489	2183245673-692				5	56561086-086	17103580-584
			40	66749962-962	6883776721-760				5	56561086-086	17292488-492
2	28828748	Amit Bansal		50613907-907					5	56561086-086	17406603-607
			6		1161017884-889
		Suman Bansal	36	58416207-207	1623167532-567				5	56561086-086	17463202-206
			42	62575400-400	2216220610-651				5	56561086-086	17518861-865
			84	66857104-104	6892430065-148				15	56561086-086	17547525-539
3	24257801	Ashok Sureshchandra Ba	165	16424466-470	408316870-034				5	56561086-086	17629163-167
		Shama Ashok Bal	165	62486267-267	2209628573-737				5	56561086-086	17729208-212
4	50308553	Bhavna Sagar	20	10643405-405	190292481-500	3	64187104	Manjula S	10	11505664-664	207530912-921
			170	66409920-920	6853503808-977				$\overline{10}$	54408827-827	1288218984-993
5	32825753	Bipinkumar Amrutlal	162	62373661-661	2198257494-655				40	66815301-301	6889046968-007
		Arkman				4	35073230	Mohamed Ashraf	20	4523395-395	73677199-218
		Smitaben Amrutlal Arkman						Nagarwala	9	7598874-875	147954485-493
6	28348517	Chandan Kumar De	40	3592476-477	55058819-858			Mohamed Salim Meman	$\overline{10}$	10479171-171	187587393-402
			50	10600103-103	189464164-213				7	12697197-197	257125773-779
7	47990548	Charushila Gulanikar	40	15484484-484
					261163046-085				$\overline{\mathbf{c}}$	14222078-079	331374850-851
		Abhijit Gulanikar	$\overline{10}$ 50	15484484-484 51130236-236	331120890-899				30	16730675-676	468040030-059
					1171282628-677				78	53677295-297	1257377658-735
8	70293447	Harjit Chohan	60	62414957-957	2203359698-757				156	62460256-256	2207544976-131
		Kawaljit Chohan	120	66664218-218	6875726679-798	15	70878500	Parasra M Wadhwani	60	62208818-818	2185054753-812
9	55932042	Jayasree Sengupta	20	11582075-075	209181453-472	16	28710712	Parimal Chattopadhayay	20	3640291-291	56015119-138
		Akhil Kumar Sengupta	20	50925534-534	II65464084-103			Alpana Chattopadhyay	80	66875557-557	6893971543-622
		Aparna Sengupta	80	66877667-667	6894137081-160	17	7450494	Ranjan Nalin Parikh	20	5280698-698	86752715-734
$\overline{0}$	67001559	Kamal Kishor Verma	25	16631384-384	466090170-194			Ameet Nalin Parikh	15	6582317-317	138192180-194
			25	50960007-007	II66247028-052				55	14599997-998	391070295-349
			25	56981071-071	389266025-049				90	62383371-371	2199407641-730
П	82920200	Kishorsinh R Chauhan	54	57450001-002	1592402289-342	8	72012933	Ravi Wadhwani	60	62208849-849	2185056496-555
		Bhavansinh K Chauhan				9	130052226	Sandeep Banga	8	57517804-804	1594491542-559
12	48015255	Madhu Devi Saraf	50	1011642-642	25307060-109				8	61831269-269	2180324485-502
			20	2455004-004	49405508-527				36	66427074-074	6855169202-237
			20	2455004-004	50567458-477	20	32401341	Sandeep Mansukhani	40	4164579-580	66500879-918
			5	2455004-004	50567498-502			Lachman Chellaram	130	62214382-382	2185587222-351
			5	2455004-004	50567508-512	21	55034800	Savitri Bhagwandas Gupta	20	11419291-291	205747498-517
			50	7977809-809	159334953-002			Bhagwandas Ramcharan	20	50894449-449	II64842384-403
			50	8040191-191	103405799-848			Gupta	36	58389157-157	1621972191-226
			$\overline{10}$	8074779-779	15539334-343				76	62486458-458	2209648914-989
			15	8074779-779	24365131-145				152	66746515-515	6883505057-208
			16	8074779-779	42269487-502
			4	8074779-779	45583478-481	22	84302023	Shubha Srivastava	20	50844784-784	1163849084-103
			5	8074779-779	49470713-717				25	50978594-594	1166711703-727
			3	8106368-368	141444913-925				20	59460899-899	192922903-922
			5	8106368-368	141445901-905				25	59586312-312	466401770-794
			8	8106368-368	141949218-225				40	62275988-988	2190618069-108
			16						50	62275992-992	2190618319-368
			8	8106368-368 8106368-368	148981731-746 149208692-699	23	31626749	Suresh Tulshiram Kamthe	$\overline{10}$	7272653-653	145369117-126
			10					Tulshiram Genu Kamthe	140	66696424-424	6879052840-979
			40	8135629-629	68706069-078 69711159-198			Shwganga Tulshiram
			100	8135629-629				Kamthe
				8215688-689	126599469-568	24	66971708	Urmil Banga	25	14524780-780	389229025-049
			20 10	8466318-318	72025879-898				25	50958939-939	1166220328-352
				8466318-318	72033899-908				50	62230159-159	2187024938-987
			20	8466318-318	72034039-058				100	66426896-896	6855157862-961
			30	8467028-028	84126863-892	25	53679714	V Lalita Subramoni	20	11545356-356	208362048-067
			20	8467028-028	84127493-512			SV Subramoni lyer	20	50918297-297	1165319344-363
			14	8502839-839	52558185-198				40	62574277-277	2216123164-203
			20	8502839-839	52567299-318	26	67711211	V. Lalithambal	25	16110102-102	402555570-594
			16	8502839-839	70810239-254			SV Subramoni lyer	25	51071187-187	1169026528-552
			50	8770606-606	949301-350				50	62574289-289	2216123877-926
			50	8770607-607	973351-400	27	9403230	Vaidya Alka Shantilal	50	7999112-112	160360297-346
			50	8770608-608	983751-800			Vaidya Shantilal	50	62651823-823	2222436587-636
			50	8770611-611	1001701-750			Harishanker	100	66914881-881	6898450074-173
			$\overline{10}$	9101668-668	101291779-788	28	100203262	Vilas Singhan	18	58104348-348	1611699770-787
			40	9101668-668	101291929-968				8	62070141-141	2183096694-711
			50	9590116-116	122135415-464				36	66734632-632	6882562787-822
			50	9675677-677	299025658-707	29	102896834	Yogesh Anand	8	57519570-570	1594541861-878
			50	9675681-681	299025858-907				8	61832428-428	2180338557-574
			50	9675683-683	299025958-007				36	66428629-629	6855345376-411
			50	9675685-685	299026058-107			Total	7521
			50	11860711-711	219179475-524
			50	16003025-025	399646490-539			The Public is hereby warned against purchasing or dealing with these securities any way. Any person(s) who has / have any claim in regard of the securities, should lodge such claim
			50	16003027-027	399646590-639			with the Company's Registrar and Transfer Agents viz. "KFin Technologies Private
					399838235-284
			50	16007479-479
			50	16007528-528	399840685-734						Limited", Selenium Tower B, Plot No. 31-32, Gachibowli, Financial District, Nanakramguda,
			50	20041420-420	211213933-982			Hyderabad - 500 032, within Seven (7) days from the date of publication of this notice,
			50	20041796-796	106369059-108			failing which, the Company will proceed to issue duplicate certificate(s) in respect of the
			50	54348073-073	1285253291-340		aforesaid securities.
			150	54398698-700	1287782527-676					for Reliance Industries Limited
			50	54398884-884	1287791827-876					Sd/-
			50	54399942-942	1287844727-776		Place: Mumbai Date: September 17, 2021			Savithri Parekh	Joint Company Secretary and Compliance Officer
						www.ril.com

Reliance
Industries Limited
Growth is Life
1aker Chambers IV, 222, Nariman Poir
-3555 5000. Email: investor.relations@

	of duplicate certificate(s).	to have been lost or misplaced and Registered Holders thereof have applied for the issue							100 50	54401140-141 54981702-702	1287904627-726 1335857316-365
Sr.	Folio No.	Name / Joint Names		Shares Certificate Nos.	Distinctive Nos.				$\overline{10}$	55921797-797	57915439-448
No. $\overline{\phantom{a}}$			10	From - To	From - To				40 400	55921797-797	58394999-038 302906178-577
	63097527	Ajay Zunzunwalla	0	11423030-030 50712086-086	205833322-331 1161912697-706				50	55938119-126 56365802-802	153528454-503
			20	62081489-489	2183245673-692				5	56561086-086	17103580-584
$\mathbf 2$	28828748	Amit Bansal	40 6	66749962-962 50613907-907	6883776721-760 1161017884-889				5 5	56561086-086 56561086-086	17292488-492 17406603-607
		Suman Bansal	36	58416207-207	1623167532-567				5	56561086-086	17463202-206
			42	62575400-400	2216220610-651				5	56561086-086	17518861-865
3	24257801	Ashok Sureshchandra Bal	84 165	66857104-104 16424466-470	6892430065-148 408316870-034				15 5	56561086-086 56561086-086	17547525-539 17629163-167
		Shama Ashok Bal	165	62486267-267	2209628573-737				5	56561086-086	17729208-212
$\overline{4}$	50308553	Bhavna Sagar	20 170	10643405-405 66409920-920	190292481-500 6853503808-977	13	64187104	Manjula S	0	11505664-664	207530912-921 1288218984-993
5	32825753	Bipinkumar Amrutlal	162	62373661-661	2198257494-655				$\overline{10}$ 40	54408827-827 66815301-301	6889046968-007
		Arkman				4	35073230	Mohamed Ashraf	20	4523395-395	73677199-218
6	28348517	Smitaben Amrutlal Arkman Chandan Kumar De	40	3592476-477	55058819-858			Nagarwala Mohamed Salim Meman	9 10	7598874-875 10479171-171	147954485-493 187587393-402
$\overline{7}$	47990548		50	10600103-103	189464164-213				7	12697197-197	257125773-779
		Charushila Gulanikar Abhijit Gulanikar	40 $\overline{10}$	15484484-484 15484484-484	261163046-085 331120890-899				$\overline{2}$ 30	14222078-079 16730675-676	331374850-851 468040030-059
			50	51130236-236	1171282628-677				78	53677295-297	1257377658-735
8	70293447	Harjit Chohan Kawaljit Chohan	60 120	62414957-957 66664218-218	2203359698-757 6875726679-798	15	70878500	Parasra M Wadhwani	156 60	62460256-256 62208818-818	2207544976-131 2185054753-812
9	55932042	Jayasree Sengupta	20	11582075-075	209181453-472	16	28710712	Parimal Chattopadhayay	20	3640291-291	56015119-138
		Akhil Kumar Sengupta Aparna Sengupta	20 80	50925534-534 66877667-667	II65464084-103 6894137081-160			Alpana Chattopadhyay	80	66875557-557	6893971543-622
0	67001559	Kamal Kishor Verma	25	16631384-384	466090170-194	17	7450494	Ranjan Nalin Parikh Ameet Nalin Parikh	20 15	5280698-698 6582317-317	86752715-734 138192180-194
			25	50960007-007	1166247028-052				55	14599997-998	391070295-349
$\mathsf{I}$	82920200	Kishorsinh R Chauhan	25 54	56981071-071 57450001-002	389266025-049 1592402289-342	8	72012933	Ravi Wadhwani	90 60	62383371-371 62208849-849	2199407641-730 2185056496-555
		Bhavansinh K Chauhan				9	130052226	Sandeep Banga	8	57517804-804	1594491542-559
2	48015255	Madhu Devi Saraf	50 20	1011642-642 2455004-004	25307060-109 49405508-527				8	61831269-269	2180324485-502
			20	2455004-004	50567458-477	20	32401341	Sandeep Mansukhani	36 40	66427074-074 4164579-580	6855169202-237 66500879-918
			5 5	2455004-004 2455004-004	50567498-502 50567508-512			Lachman Chellaram	130	62214382-382	2185587222-351
			50	7977809-809	159334953-002	21	55034800	Savitri Bhagwandas Gupta Bhagwandas Ramcharan	20 20	11419291-291 50894449-449	205747498-517 II64842384-403
			50 10	8040191-191	103405799-848			Gupta	36	58389157-157	1621972191-226
			15	8074779-779 8074779-779	15539334-343 24365131-145				76 152	62486458-458 66746515-515	2209648914-989 6883505057-208
			16	8074779-779	42269487-502	22	84302023	Shubha Srivastava	20	50844784-784	1163849084-103
			$\overline{4}$ 5	8074779-779 8074779-779	45583478-481 49470713-717				25 20	50978594-594 59460899-899	1166711703-727 192922903-922
			13	8106368-368	141444913-925				25	59586312-312	466401770-794
			5 8	8106368-368 8106368-368	141445901-905 141949218-225				40	62275988-988	2190618069-108
			16	8106368-368	148981731-746	23	31626749	Suresh Tulshiram Kamthe	50 $\overline{10}$	62275992-992 7272653-653	2190618319-368 145369117-126
			8	8106368-368	149208692-699			Tulshiram Genu Kamthe	140	66696424-424	6879052840-979
			10 40	8135629-629 8135629-629	68706069-078 69711159-198			Shwganga Tulshiram Kamthe
			100	8215688-689	126599469-568	24	66971708	Urmil Banga	25	14524780-780	389229025-049
			20 0	8466318-318 8466318-318	72025879-898 72033899-908				25 50	50958939-939 62230159-159	1166220328-352 2187024938-987
			20	8466318-318	72034039-058				100	66426896-896	6855157862-961
			30	8467028-028 8467028-028	84126863-892	25		53679714 V Lalita Subramoni	20	11545356-356	208362048-067
			20 4	8502839-839	84127493-512 52558185-198			SV Subramoni lyer	20 40	50918297-297 62574277-277	1165319344-363 2216123164-203
			20	8502839-839	52567299-318	26	67711211	V. Lalithambal	25	16110102-102	402555570-594
			16 50	8502839-839 8770606-606	70810239-254 949301-350			SV Subramoni lyer	25 50	51071187-187 62574289-289	1169026528-552 2216123877-926
			50	8770607-607	973351-400	27	9403230	Vaidya Alka Shantilal	50	7999112-112	160360297-346
			50 50	8770608-608 8770611-611	983751-800 1001701-750			Vaidya Shantilal Harishanker	50 100	62651823-823 66914881-881	2222436587-636 6898450074-173
			$\overline{10}$	9101668-668	101291779-788	28	100203262	Vilas Singhan	8	58104348-348	1611699770-787
			40 50	9101668-668 9590116-116	101291929-968 122135415-464				8 36	62070141-141 66734632-632	2183096694-711 6882562787-822
			50	9675677-677	299025658-707	29	102896834	Yogesh Anand	8	57519570-570	1594541861-878
			50 50	9675681-681 9675683-683	299025858-907 299025958-007				8	61832428-428	2180338557-574
			50	9675685-685	299026058-107				36	66428629-629	6855345376-411
			50 50	11860711-711 16003025-025	219179475-524 399646490-539			Total The Public is hereby warned against purchasing or dealing with these securities any way.	7521
			50	16003027-027	399646590-639			Any person(s) who has / have any claim in regard of the securities, should lodge such claim
			50	16007479-479	399838235-284			with the Company's Registrar and Transfer Agents viz. "KFin Technologies Private Limited", Selenium Tower B, Plot No. 31-32, Gachibowli, Financial District, Nanakramguda,
			50 50	16007528-528 20041420-420	399840685-734 211213933-982			Hyderabad - 500 032, within Seven (7) days from the date of publication of this notice,
			50	20041796-796	106369059-108		aforesaid securities.	failing which, the Company will proceed to issue duplicate certificate(s) in respect of the
			50 150	54348073-073 54398698-700	1285253291-340 1287782527-676	for Reliance Industries Limited
			50	54398884-884	1287791827-876	Sd/- Savithri Parekh Place: Mumbai
			50	54399942-942	1287844727-776		Date: September 17, 2021				Joint Company Secretary and Compliance Officer
						www.ril.com

Available for Rent/Long Lease Nariman Point Prime Building * 5250 sqft carpet Fully Furnished *3000 sqft carpet Fully Furnished * 1560 Sqft carpet Fully Furnished *1500 sqft carpet Bare Shell

or Mail: SOBO.Offices@gmail.com

Contact : 9819826432

सोलारा ॲक्टीव्ह फार्मा सायन्सेस लिमिटेड CIN: L24230MH2017PLC291636

नोंदणीकृत कार्यालय : २०१, देवब्रत, सेक्टर-१७, वाशी, नवी मुंबई - ४०० ७०३. दूर. क. : +९१ २२ २७८९२९२४, फॅक्स : +९१ २२ २७८९२९४२
कॉपरिट कार्यालय : "बत्रा सेंटर", नं. २८, सरदार पटेल रोड, गिन्डी, चेन्नई - ६०० ०३२. दूर. क. : +९१

टपाली मतदान आणि ई-मतदान सूचना

सोलारा ॲक्टीव्ह फार्मा सायन्सेस लिमिटेड ("कंपनी") यांच्या सर्व सभासदांना याद्वारे कळविण्यात येते की, कंपनी कायदा २०१३ ("कायदा") कलम ११० मधील तरतदी त्याचप्रमाणे लागू असलेल्या अन्य तरतदी, असल्यास, त्याचप्रमाणे त्यासह वाचा कंपनीज ("मॅनेजमेंट अँड ऍडमिनिस्ट्रेशन") नियम २०१४ ("नियम") चा नियम २२ आणि नियम २० यांना अनुसरुन आणि त्यासह सिक्युरिटी औड एक्स्चेन बोर्ड ऑफ इंडिया (लिस्टिंग ऑब्लिगेशन्स औड डिस्क्लोनर रिक्वायरमेंट्स) नियम २०१५ ("लिस्टिंग रेग्युलेशन्स") चा नियम ४४ आणि सामान्य परिपत्रक क्रमांक १४/२०२० दिनांकीत ८एप्रिल २०२०, सामान्य परिपत्रक क्रमांक १७/२०२० दिनांकीत १३ एप्रिल २०२०, सामान्य परिपत्रक क्रमांक २२/२०२० दिनांकीत १५ जून २०२०, सामान्य परिपत्रक क्रमांक ३३/२०२० दिनांकीत २८ सप्टेंबर २०२० सामान्य परित्रक क्रमांक ३९/२०२० दिनांकीत ३१ डिसेंबर २०२० आणि सामान्य परिपत्रक क्रमांक १०/२०२१ दिनांकीत २३ जून २०२१ जे कॉर्पोरेट व्यवहार मंत्रालय यांनी जारी केली आहेत ("एमसीए परिपत्रके") आणि अन्य आवश्यक त्या आणि लागू असलेल्या तरतदी यांना अनुसरुन सदरील प्रस्तावांना टपाली मतदानाच्या माध्यमातन दरस्थ ई-मतदान प्रक्रियेद्वारे संमती मिळविणे यासाठी टपाली ई-मतदान सचना.

सभासदांना कळविण्यात येते की, ज्या सभासदांची नावे कंपनीच्या सभासद नोंद पुस्तिका/लाभार्थी मालकांची यादी जी ढिपोझिटरीज यांनी सादर केली आहे उदा: सेंट्ल डिपॉझिटरी सर्व्हिसेस (इंडिया) लिमिटेड ("सीडीएसएल") आणि नॅशनल सिक्युरिटील लिमिटेड ("एनएसडीएल") त्याप्रमाणे त्यांच्याकडे शुक्रवार दिनांक १० सप्टेंबर, २०२१ ("कट ऑफ डेट") रोजी नॉदणीकृत आहेत अशा सभासदांना टपाली मतदान सूचना दिनांकीत २५ ऑगस्ट, २०२१, केवळ इलेक्टॉनिक माध्यमांतन निर्गमित करण्याची प्रक्रिया शक्रवार, दिनांक १७ सप्टेंबर, २०२१ रोजी पर्ण केली आहे. ज्या व्यक्ती कट ऑफ तारखेला कंपनीच्या सभासद नाहीत अशा व्यक्तींनी ही टपाली मतदान सचना केवळ माहितीसाठी आहे असे समजावे.

एमसीए यांनी जारी केलेल्या परिपत्रकानुसार, कंपनी टपाली मतदान सूचना केवळ इलेक्ट्रॉनिक माध्यमातून निर्गमित करणार आहे आणि टपाली मतदान सूचनेची प्रत्यक्ष प्रत आणि त्यासह टपाली मतदान पत्रिका आणि प्रीपेड बिझनेस रिप्लाय इन्व्हलप सभासदांना या टपाली मतदानासाठी पाठविण्यात येणार नाही आणि सभासदांनी प्रस्तावित ठरावांना आपली सहमती किंवा असहमती दरस्य आ–मतदान पद्धतीच्या माध्यमातून नोंदविणे आवश्यक आहे.

कंपनीच्या सर्व सभासदांना इलेक्टोनिक मतदान पद्धतीने मतदानाचा हक्क बजावता यावा. यासाठी कंपनी आपल्या सर्व सभासदांना दरस्थ ई-मतदान सविधा उपलब्ध करुन देत आहे. त्यासाठी कंपनीने सेंटल डिपॉझिटरी सर्व्हिसेस (इंडिया) लिमिटेड (सीडीएसएल) यांची सेवा घेतली आहे. दरस्थ ई–मतदान प्रक्रियेला शनिवार, दिनांक १८ सप्टेंबर, २०२१ रोजी भारतीय प्रमाणवेळेनसार सकाळी ९.०० वाजता प्रारंभ होईल आणि ही प्रक्रीया रविवार, दिनांक १७ ऑक्टोबर, २०२१ रोजी भारतीय प्रमाणबेळेनसार संध्याकाळी ५,०० वाजता संपुष्टात येईल.

ज्या सभासदांकडे कंपनीचे समभाग कट ऑफ तारखेला प्रत्यक्ष स्वरूपात आहेत किंवा डिमॅट स्वरूपात आहेत, असे सभासद या टपाली मतदानाच्या सूचनेत नमूद केलेल्या विषयांवर सीडीएसएल यांच्या इलेक्ट्रॉनिक मतदान पद्धतीच्या माध्यमातून (दूरस्य ई–मतदान) मतदानाचा हक्क बजावू शकतील. सभासदांना याद्वारे सूचित करण्यात येते की.

• दूरस्थ ई-मतदान प्रक्रियेला शनिवार, दिनांक १८ सप्टेंबर, २०२१ रोजी भारतीय प्रमाणवेळेनुसार सकाळी ९.०० वाजता प्रारंभ होईल.
• दूरस्थ ई-मतदान प्रक्रिया रविवार, दिनांक १७ ऑक्टोबर, २०२१ रोजी भारतीय प्रमाणवेळेनुसार संध्याकाळी ५.०० वाजता संपुष्टात येईल.
• दूरस्थ ई-मतदान प्रक्रियेच्या माध्यमातून मतदानाचा हक्क बजावण्यासाठी पात्रता निश्चित करण्यासाठी कट ऑफ तारीख शुक्रवार, दिनांक १० सप्टेंबर, २०२१ हा असेल.
• रविवार, दिनांक १७ ऑक्टोबर, २०२१ रोजी संध्याकाळी ५.०० वाजता दरस्थ ई-मतदान प्रारूप बंद करण्यात येईल आणि सदरील तारीख आणि वेळेनंतर मतदान करता येणार नाही.
• दूरस्थ ई-मतदानाची सविस्तर प्रक्रिया टपाली मतदान सूचनेत नमूद करण्यात आली आहे. टपाली मतदानाची सूचना कंपनी यांचे संकेतस्थळ www.solara.co.in आणि सीडीएसएल यांचे संकेतस्थळ www.evotingindia.com येथून डाउनलोड करता येईल.

टपाली मतदान ई–मतदान प्रक्रिया योग्य आणि पारदर्शक पद्धतीने व्हावी, यासाठी कंपनीच्या संचालक मंडळ यांनी मेसर्स प्रीतम हेब्बर आणि कंपनी, प्रॅक्टिसिंग कंपनी सेक्रेटरी यांचे श्री प्रीतम हेब्बर (सीओपी क्रमांक २१४३१) यांची छाननी अधिकारी म्हणून नियुक्ती केली आहे.

संचालक मंडळाने प्राधिकत केल्यानुसार, दरस्थ ई-मतदान प्रक्रियेची संपूर्ण छाननी केल्यानंतर छाननी अधिकारी आपला अहवाल अध्यक्ष किंवा कंपनीच्या कोणत्याही संचालकाकडे सादर करील. हा कालावधी टपाली मतदान प्रक्रिया पूर्ण झाल्यानंतर ४८ तासांपेक्षा अधिक असणार नाही. आणि टपाली मतदानाचे निकाल मंगळवार, दिनांक १९ ऑक्टोबर रोजी भारतीय प्रमाणवेळेनुसार संध्याकाळी ५.०० वाजता किंवा त्यापुर्वी कधीही जाहीर करण्यात येतील. टपाली मतदानाचे निकाल आणि छाननी अधिकाऱ्याचा अहवाल, जिथे कंपनीच्या प्रतिभूती नोंदणीकृत आहेत त्या स्टॉक एक्सचेंजकडे सादर करण्यात येतील त्याचप्रमाणे कंपनी यांच्या नोंदणीकृत कार्यालयात आणि कॉर्पोरेट कार्यालयात सूचना फलकावर प्रसिद्ध करण्यात येतील. त्याचप्रमाणे ते संकेतस्थळ www.solara.co.in येथे अपलोड करण्यात येतील.

दरस्य ई-मतदान प्रक्रियेसंदर्भात कोणत्याही स्वरूपाची शंका किंवा प्रश्न असल्यास सभासद http://www.evotingindia.com येथे डाउनलोड विभागात उपलब्ध असलेल्या सभासदांकरिता उपलब्ध असलेल्या ई-वोटिंग युजर म्यॅनुअल किंवा सभासदांकरिता उपलब्ध असलेल्या फ्रिक्वेन्टली आस्कड क्वेशन्स यांचा संदर्भ घेऊ शकतात. किंवा आपण helpdesk.evoting@cdslindia.com येथे ई-मेल करू शकता किंवा श्री नितीन कुंडेर (०२२–२३०५८७३८) किंवा श्री मेहबुब लखानी (०२२-२३०५८५४३) किंवा श्री राकेश दळवी (०२२-२३०५८५४२) यांच्याशी संपर्क साध शकतात किंवा कंपनी यांचे आरटीए मेसर्स केंमिओ कॉर्पोरेट सर्व्हिसेस लिमिटेड, सुब्रमणियन बिल्डिंग १, क्लब हाऊस रोड, चेन्नई ६०० ००२, भारत दरध्वनी क्रमांक +९१ ४४ २८४६ ०३९० फेंक्स: +९१ ४४ २८४६ ०१२९ ई-मेल तपशील : investor@cameoindia.com येथे किंवा संपर्क व्यक्ती : श्रीमती कोमला यांच्याशी संपर्क साध शकतात.

इलेक्टोनिक मतदान पद्धतीने देण्यात येणाऱ्या मतदान सुविधेसंदर्भात शंकांचे समाधान करण्यासाठी श्री राकेश दळवी. व्यवस्थापक, सेंटल डिपॉझिटरी सर्व्हिसेस (इंडिया) लिमिटेड, ए विंग, २५वा मजला, मेरैथॉन फ्युचरेक्स, मफतलाल मिल कंपाउंड, एन. एम. जोशी मार्ग, लोअर परळ (पूर्व) मुंबई - ४०० ०१३ यांच्याकडे ई-मेल तपशील helpdesk.evoting@cdslindia.com येथे संपर्क साधावा.

स्थळ : चेन्नई दिनांक : १७ सप्टेंबर, २०२१

संचालक मंडळाच्या आदेशानुसार सोलारा ॲक्टीव्ह फार्मा सायन्सेस लिमिटेड यांच्या करिता सही/-.
एस. मुरली कृष्णा
कंपनी सेक्रेटरी

Mumbai Main Page No. 9 Sep 18, 2021 Powered by: erelego.com